BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics. - Wikidata - wikimedia - TriplyDB

BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics.

BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics.

http://www.wikidata.org/entity/Q33305172

about

TMEM165 deficiency causes a congenital disorder of glycosylation Gliding Motility of Mycoplasma mobile on Uniform Oligosaccharides High-Throughput Analysis and Automation for Glycomics Studies Functional network of glycan-related molecules: glyco-net in glycoconjugate data bank.Protein modifications as potential biomarkers in breast cancer.Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell differentiation.Challenges to developing proteomic-based breast cancer diagnostics.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.Sialic acid-focused quantitative mouse serum glycoproteomics by multiple reaction monitoring assay.Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis.Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera.Glycomic analysis using glycoprotein immobilization for glycan extraction.Glycomic analysis by glycoprotein immobilization for glycan extraction and liquid chromatography on microfluidic chip.A comparison of N-glycan profiles in human plasma and vitreous fluid.Sample preparation for mass spectrometric analysis of human serum N-glycans using hydrophilic interaction chromatography-based solid phase extraction.Development of a novel system for mass spectrometric analysis of cancer-associated fucosylation in plasma α1-acid glycoprotein A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.Lectin-based structural glycomics: a practical approach to complex glycans.Relative versus absolute quantitation in disease glycomics.State-of-the-art technologies for rapid and high-throughput sample preparation and analysis of N-glycans from antibodies.Reliable LC-MS quantitative glycomics using iGlycoMab stable isotope labeled glycans as internal standards.Quantitative glycomics using liquid phase separations coupled to mass spectrometry.Effect of ganglioside GM3 synthase gene knockout on the glycoprotein N-glycan profile of mouse embryonic fibroblast.Glycomics for drug discovery: metabolic perturbation in androgen-independent prostate cancer cells induced by unnatural hexosamine mimics.Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.Glycosylation specific for adhesion molecules in epidermis and its receptor revealed by glycoform-focused reverse genomics.An Efficient Glycoblotting-Based Analysis of Oxidized Lipids in Liposomes and a Lipoprotein.

P2860

Q24337807-F19CAD0F-03DA-4992-AA0B-217449232EF0 Q27322427-0A157B0E-3C97-45B9-9A1D-715154BDFE79 Q28080479-43B72BB0-D88E-42AF-8BAF-5B497788EC0E Q33452691-8EC0FF00-62D8-432E-8A43-E74CC6D57EBB Q33586407-B99EC547-1CED-4D66-9D6A-575D621EB423 Q33770148-DED7BB0E-5D9F-41CE-BBD6-C66C2B0CF760 Q33823926-A4A09772-A1D3-4443-819B-0F4BAD43381C Q33995843-0B1EA633-4C91-4038-8AE7-CF19DE7097DF Q34320706-ADD8FDBA-1BE9-46EC-936C-CA2139E2D915 Q34549268-40F7B84F-B750-4197-AE07-484B08A4501E Q34597839-36F308B7-A279-4CB7-8EE2-2A2CF1F6A96F Q34729056-F9D05619-4BBC-44D9-A4D6-467B83FD28AE Q35013214-50B9695C-8C23-4EF6-8E79-EC0C8258D835 Q35184247-9FADC0D0-EB0C-4453-A521-0D2F364D1809 Q35213998-5F96E091-C245-40CC-8BFC-59540558A9BB Q36651283-1C3774BB-9CC8-4934-A0B3-C4C05D341B18 Q37634119-00D2E361-D92A-499C-97D6-829158062B55 Q37872259-22E05C89-AAAC-45E8-BB64-11F730EAB77B Q38356585-CC01C860-4243-4AEE-B491-98A84D2583D3 Q38717803-2127E075-5C9F-4B84-8C02-934D1248E3D4 Q38791165-3B50A905-5404-4927-ABDD-335696D5880A Q39124498-63ED2DBF-649B-4B23-94A3-19CFF1A5D0E4 Q39229360-63A50396-4536-4CA5-99AA-4E83E23421D1 Q39394553-DF89D59F-8836-4046-885B-4E998C8A8036 Q41573946-48E1CECB-EE38-4268-AB65-201BBED080B4 Q43871500-0A0F7A67-299C-496D-98D1-0BD867A79192 Q46325442-17C8EE9C-9C81-45DE-A156-E3ECF0673B0B

P2860

BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics.

http://www.wikidata.org/entity/Q33305172

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@ast

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@en

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@nl

type

label

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@ast

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@en

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@nl

prefLabel

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@ast

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@en

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@nl

P1433

Q33305172-832DC65A-EFF2-4247-8A4C-9B513AED0A23

P1476

Q33305172-712E6974-8DE0-4EF0-AA1C-BA493FA8B4AD

P2093

Q33305172-1B843475-CCCC-4DD8-ADE1-22705185E1B5

Q33305172-309BC292-93AD-447B-BA55-1516F79F9E07

Q33305172-5CCB3101-683E-428B-B740-A136510700EB

Q33305172-65809884-455F-43BF-BE0C-EFF9166A2D61

Q33305172-7B53B002-2002-4E31-A3E3-A1B7D69BFAAE

Q33305172-8F0AA179-1EB1-4BCC-A953-FAA217D1A6A5

Q33305172-9763A3E0-B672-4EE2-B4B6-07379D3B010B

Q33305172-986174A9-F55C-4D56-ABF6-7804AA311B3E

Q33305172-DFEDD84C-A712-49B9-8745-D226E3C7DB86

Q33305172-E8425EF6-3171-44B4-A561-2745107FFE38

P2860

Q33305172-0B3F896F-2D0B-47AE-AB86-30C5FB96DA95

Q33305172-15E9DAFC-BE47-4105-8CF8-5A33F259FC4C

Q33305172-23ED49DD-73CC-4CC2-8DB6-F18785AF61A8

Q33305172-241BCA27-D895-4CEA-9BA8-E19DCF80605C

Q33305172-25DB164C-ABB6-4540-A25E-EBBAA3D853A5

Q33305172-27D2721C-BFB0-4388-B625-CFBA2DA197A2

Q33305172-461BC2FE-8664-42E1-A827-A5A32D095555

Q33305172-4622EDBD-D061-4F14-A3F6-7962C266DD35

Q33305172-536CEEAD-92FD-441F-932A-8DA1C7CFFE28

Q33305172-64970EC8-A08D-463A-8E8D-6491FCED04E3

P304

Q33305172-CE154585-38D8-4360-B85C-31E838BC0237

P31

Q33305172-C7A8AF07-B1B1-4FA7-809E-637D0002B159

P356

Q33305172-308613FB-2B98-468D-8B78-5A0683E59E2A

P433

Q33305172-155CE6C0-AF1B-4D5C-AF15-FF7C07A8D21E

P478

Q33305172-A72640FB-D0A8-409C-8240-25D6F5B9007A

P577

Q33305172-F5DA25E3-0A53-46B3-9EFA-DC34BF7C736F

P5875

Q33305172-9530F527-B6D2-4F0E-AA32-4F4895F177F8

P698

Q33305172-A82B4802-0DEC-41F7-A293-F6FAE0696A4C

P356

MCP.M700377-MCP200

P1433

Molecular & Cellular Proteomics

P1476

BlotGlycoABCTM, an integrated ...... arge scale clinical glycomics.

@en

P2093

Hideyuki Shimaoka

http://www.w3.org/2001/XMLSchema#string

Hiromitsu Kuramoto

http://www.w3.org/2001/XMLSchema#string

Jun-ichi Furukawa

http://www.w3.org/2001/XMLSchema#string

Kazuaki Nakanishi

http://www.w3.org/2001/XMLSchema#string

Masaki Kurogochi

http://www.w3.org/2001/XMLSchema#string

Megumi Hato

http://www.w3.org/2001/XMLSchema#string

Michitaka Ozaki

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Tada

http://www.w3.org/2001/XMLSchema#string

Satoru Todo

http://www.w3.org/2001/XMLSchema#string

Shin-Ichiro Nishimura

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder

High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry.

Rapid and simple solid-phase esterification of sialic acid residues for quantitative glycomics by mass spectrometry.

Derivatization for stabilizing sialic acids in MALDI-MS.

Structural characterization of N-glycopeptides by matrix-dependent selective fragmentation of MALDI-TOF/TOF tandem mass spectrometry.

Glycoprotein structure determination by mass spectrometry.

Versatile glycoblotting nanoparticles for high-throughput protein glycomics.

High throughput quantitative glycomics and glycoform-focused proteomics of murine dermis and epidermis.

Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis.

Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation.

P304

370-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M700377-MCP200

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5861164

http://www.w3.org/2001/XMLSchema#string

P698

17986439

http://www.w3.org/2001/XMLSchema#string